Literature DB >> 7839071

An 8-year follow-up study of pulmonary function in patients with rheumatoid arthritis.

M Linstow1, C S Ulrik, N J Kriegbaum, V Backer, P Oxholm.   

Abstract

To evaluate longitudinal alterations in pulmonary function, 63 patients suffering from rheumatoid arthritis (RA) with previously reported reduced pulmonary diffusing capacity were re-examined in an 8-year follow-up study. Cross-sectional examination revealed normal values for vital capacity (VC), forced expiratory volume in 1 s (FEV1) and diffusing capacity per litre alveolar volume (KCO). Total diffusing capacity (DLCO; P < 0.0001), maximal expiratory flow at 75% of expired VC (MEF75; P < 0.0001) and MEF50 (P < 0.01) were decreased. Longitudinal evaluation revealed unchanged MEF50, MEF75 and FEV1, whereas increases in DLCO (P < 0.0001) and KCO (P < 0.0001) and a decrease in VC (P < 0.05) were found. The longitudinal changes in diffusing capacity were unrelated to patient age, disease duration, disease activity in the study period or pulmonary function at the first examination. Thus, in patients suffering from RA, the most prominent functional pulmonary abnormality, decreased diffusing capacity, appeared to improve in the course of time, despite a slight decrease in VC and continued articular disease activity.

Entities:  

Mesh:

Year:  1994        PMID: 7839071     DOI: 10.1007/bf00300812

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  PULMONARY DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS.

Authors:  H M BRANNAN; C A GOOD; M B DIVERTIE; A H BAGGENSTOSS
Journal:  JAMA       Date:  1964-09-21       Impact factor: 56.272

2.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

3.  The arteritis of rheumatoid arthritis.

Authors:  B CRUICKSHANK
Journal:  Ann Rheum Dis       Date:  1954-06       Impact factor: 19.103

4.  Rheumatoid disease with joint and pulmonary manifestations.

Authors:  P ELLMAN; R E BALL
Journal:  Br Med J       Date:  1948-11-06

5.  Penicillamine for interstitial lung disease in rheumatoid arthritis.

Authors:  A C van der Schee; B A Dinkla; J J Festen
Journal:  Respiration       Date:  1989       Impact factor: 3.580

6.  Pulmonary injury induced by gold salts treatment.

Authors:  D Schapira; M Nahir; Y Scharf
Journal:  Med Interne       Date:  1985 Oct-Dec

7.  Interstitial rheumatoid lung disease. A reassessment and review of the literature.

Authors:  M S Popper; M L Bogdonoff; R L Hughes
Journal:  Chest       Date:  1972-09       Impact factor: 9.410

8.  Smoking, lung function, and rheumatoid factors.

Authors:  T Tuomi; M Heliövaara; T Palosuo; K Aho
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

9.  Comparison of pulmonary function in patients with systemic lupus erythematosus, scleroderma, and rheumatoid arthritis.

Authors:  C T Huang; H A Lyons
Journal:  Am Rev Respir Dis       Date:  1966-06

10.  A three-year prospective study of systemic manifestation in rheumatoid arthritis.

Authors:  H Mielke; W Daniel; H Deicher; W Drommer; M Fischer; R Fritsch; H Müller-Vahl; G W Sybrecht
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

View more
  2 in total

1.  Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis.

Authors:  B Cortet; T Perez; N Roux; R M Flipo; B Duquesnoy; B Delcambre; M Rémy-Jardin
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

2.  Small airways involvement in patients with rheumatoid arthritis.

Authors:  Mohammad Ali Zohal; Zohreh Yazdi; Ali Rassi Ghaemi; Mahnaz Abbasi
Journal:  Glob J Health Sci       Date:  2012-12-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.